Cradle
Cradle sells a protein-engineering platform where scientists design new proteins, optimize properties such as efficacy, developability and manufacturability in parallel, and feed each round of experimental data into the next. It covers antibodies, enzymes, peptides and vaccines for biopharma, industrial and academic teams.
Product
Selected offerings — the AI products recorded here, not the vendor's full catalogue.
-
Cradle Platform
Designs and optimises protein sequences with machine-learning models trained on a customer's own lab results.
Similar products 13
No sourced competitor yet: no filing, vendor document or measured-market report read so far names a rival for this company, so none is asserted. The companies below are the closest by what their products do.
Closest alternatives are pairs a vendor page itself compares. Similar products are matched from what each product does; nothing in that group is asserted as a rivalry.
Sources
- Stage, from total funding
-
"This brings our total funding to over $100 million." Cradle's own Series B post; the sum of disclosed rounds (~$5.5M seed + $24M A + $73M B ≈ $102.4M) matches.
- Founded
-
Infobox: "Founded May 2021; 5 years ago (2021-05)".
- Description
-
Official documentation · 10 Oct 2026
The AI protein engineering software built for scientists
Something wrong here? Send a correction — quote this company id: cradle.